Call Options

21 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $141,744 - $181,728
-2,400 Reduced 7.32%
30,400 $2.25 Million
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $1.27 Million - $1.91 Million
19,300 Added 142.96%
32,800 $2.24 Million
Q1 2023

May 12, 2023

SELL
$47.19 - $70.77 $2.48 Million - $3.72 Million
-52,600 Reduced 79.58%
13,500 $915,000
Q4 2022

Feb 10, 2023

BUY
$30.35 - $53.15 $658,595 - $1.15 Million
21,700 Added 48.87%
66,100 $3.27 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $949,509 - $1.47 Million
29,700 Added 202.04%
44,400 $1.44 Million
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $1.56 Million - $3.34 Million
-43,800 Reduced 74.87%
14,700 $579,000
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $3.06 Million - $4.39 Million
-53,200 Reduced 47.63%
58,500 $4.09 Million
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $1.99 Million - $2.76 Million
-27,400 Reduced 19.7%
111,700 $8.69 Million
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $5.56 Million - $7.64 Million
61,600 Added 79.48%
139,100 $13.3 Million
Q2 2021

Aug 13, 2021

SELL
$93.66 - $139.27 $5.71 Million - $8.5 Million
-61,000 Reduced 44.04%
77,500 $9.63 Million
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $51.1 Million - $67.9 Million
-438,000 Reduced 75.98%
138,500 $18.3 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $2.07 Million - $2.96 Million
20,800 Added 3.74%
576,500 $76.4 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $28 Million - $39.2 Million
383,900 Added 223.46%
555,700 $56.7 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $6.45 Million - $10.7 Million
115,700 Added 206.24%
171,800 $14.9 Million
Q1 2020

May 14, 2020

SELL
$37.9 - $104.44 $5.19 Million - $14.3 Million
-137,000 Reduced 70.95%
56,100 $3.25 Million
Q4 2019

Feb 13, 2020

BUY
$77.66 - $99.74 $5.17 Million - $6.64 Million
66,600 Added 52.65%
193,100 $17.9 Million
Q3 2019

Nov 08, 2019

BUY
$90.37 - $122.49 $713,923 - $967,671
7,900 Added 6.66%
126,500 $11.4 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $7.21 Million - $9.5 Million
80,500 Added 211.29%
118,600 $14 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $5.87 Million - $9.14 Million
-94,700 Reduced 71.31%
38,100 $3.3 Million
Q4 2018

Feb 13, 2019

BUY
$56.04 - $82.66 $6.2 Million - $9.14 Million
110,600 Added 498.2%
132,800 $8.38 Million
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $1.07 Million - $1.79 Million
22,200 New
22,200 $1.75 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.